WS #4694

The data window reveals a significant escalation in Middle East geopolitical tensions, directly impacting energy markets, inflation expectations, and consumer confidence. Multiple sources corroborate new military actions: Ukraine strikes Lukoil drilling platforms in the Caspian Sea, and Israel conducts massive bombardment of Beirut, with Hezbollah targeting civilians. Concurrently, Iran sets conditions for US negotiations, demanding a ceasefire in Lebanon and release of frozen assets, indicating diplomatic hurdles. This geopolitical stress is translating into concrete economic pressures: US consumer confidence plunges to a record low of 47.6 in April due to Iran war fears and energy price spikes, with year-ahead inflation expectations at 4.8%. The Energy Information Administration reports gas prices jumped 25% from February to March, the highest monthly increase on record. Goldman Sachs warns that higher gas prices and inflation will negate recent tax cuts. These developments create a dual pressure: escalating conflict risk and an imminent inflation shock, which could prompt Federal Reserve hawkishness despite a lower-than-expected core inflation print for March (0.2% MoM, 2.6% YoY). In corporate news, Replimune Group shares trade lower after FDA issues a complete response letter for its melanoma drug, a negative catalyst for biotech. Hong Kong greenlights stablecoins, with HSBC and Standard Chartered winning first licenses, a positive for digital finance and HSBC stock. Analyst actions include Barclays raising price targets for Plains GP Holdings and MPLX, signaling bullishness on midstream energy infrastructure amid oil volatility.